Lisata Therapeutics (LSTA) executive Buck received 25,000 shares
Insider transactions reported
Kristen K Buck (EVP, R&D and CMO at Lisata Therapeutics Inc., LSTA) reported that they received 25,000 shares, and gave up 11,332 shares at $1.97 to cover taxes or an exercise price on Jan 9, 2026. After these transactions the filing shows 93,462 shares held directly.
- Reporting person
- Buck Kristen K
- Role
- EVP, R&D and CMO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Grant or award (A) | Common Stock1, 2 | +25,000 | - | - | 104,794 direct |
| Jan 9, 2026 | Shares withheld for taxes or exercise price (F) | Common Stock2, 3 | -11,332 | avg $1.97 | $22.3K | 93,462 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Grant or award (A) | Stock Option (Right to Buy)On 13,000 Common Stock4 | +13,000 | - | - | 13,000 direct |
Holdings before and after
- Common Stock: 79,794 to 93,462 direct
- Stock Option (Right to Buy): 0 to 13,000 direct
Footnotes from the filing
- 1. Represents 25,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- 2. Includes 38,000 unvested restricted stock.
- 3. Shares withheld as payment of a tax liability on vesting of restricted stock.
- 4. One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Buck report in this LSTA Form 4?
Kristen K Buck (EVP, R&D and CMO at Lisata Therapeutics Inc., LSTA) reported that they received 25,000 shares, and gave up 11,332 shares at $1.97 to cover taxes or an exercise price on Jan 9, 2026. After these transactions the filing shows 93,462 shares held directly.
How many LSTA shares does Buck hold after this filing?
The filing shows 93,462 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for LSTA
Across the 4 sessions after earlier LSTA headlines, the stock closed higher 2 times and lower 2 times, with a median move of 2.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | LSTA | SPY |
|---|---|---|---|
| Nov 7, 2025 | Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | -12.3% | +0.1% |
| Nov 6, 2025 | Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for 'Overall BioPharma Solution of the Year' | +0.4% | -1.1% |
| Nov 5, 2025 | Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent | -5.3% | +0.3% |
| Oct 30, 2025 | Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025 | +0.4% | -1.1% |
Earlier insider filings at LSTA
- Jan 13, 2026Director Henson Heidi was granted 30,456 shares, increasing direct ownership by 55% to 85,725 units (SEC Form 4)
- Jan 13, 2026Director Klosk Steven M was granted 30,456 shares, increasing direct ownership by 47% to 95,815 units (SEC Form 4)
- Jan 13, 2026Director Flowers Cynthia Louise was granted 30,456 shares, increasing direct ownership by 47% to 95,446 units (SEC Form 4)
- Jan 13, 2026Director Brown Gregory B was granted 30,456 shares, increasing direct ownership by 47% to 95,659 units (SEC Form 4)
- Jan 13, 2026Director Azab Mohammad was granted 30,456 shares, increasing direct ownership by 41% to 104,925 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow LSTA and get a push notification the moment its next story breaks.